Influence of hemoglobin vesicles, cellular-type artificial oxygen carriers, on human umbilical cord blood hematopoietic progenitor cells in vitro

Journal of Biomedical Materials Research - Part A

Volumn 88, Issue 1, 2009, Pages 34-42

  Yamaguchi, Miki ^a   Fujihara, Mitsuhiro ^a   Wakamoto, Shinobu ^a   Sakai, Hiromi ^b   Takeoka, Shinji ^b   Tsuchida, Eishun ^b   Azuma, Hiroshi ^a   Ikeda, Hisami ^a  

^a JAPANESE RED CROSS SOCIETY   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

Biocompatibility; Colony assay; Hematopoietic progenitor cells; Hemoglobin vesicles; Liposome encapsulated hemoglobin

Indexed keywords

BIOCOMPATIBILITY; BLOOD; CELL PROLIFERATION; CIVIL AVIATION; DIFFERENTIATION (CALCULUS); ELECTRIC CIRCUIT BREAKERS; HEMOGLOBIN; OXYGEN;

ADVERSE EFFECTS; ANIMAL MODELS; ARTIFICIAL OXYGEN CARRIERS; BONE MARROWS; CELLULAR PROLIFERATIONS; CLINICAL SETTINGS; COLONY ASSAY; CONTINUOUS EXPOSURES; HEMATOPOIETIC PROGENITOR CELLS; HEMATOPOIETIC STEM/PROGENITOR CELLS; HEMOGLOBIN VESICLES; HUMAN HEMOGLOBINS; IN VITRO; LIQUID CULTURES; MONONUCLEAR CELLS; NUMBER AND SIZES; OXYGEN CARRIERS; PROLIFERATIVE ACTIVITIES; SEMI SOLIDS; UMBILICAL CORD BLOODS;

CELL CULTURE;

BLOOD SUBSTITUTE; HEMOGLOBIN; LIPOSOME;

ARTICLE; BIOCOMPATIBILITY; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING CELL; ERYTHROID CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CULTURE; OXYGEN TRANSPORT; UMBILICAL CORD BLOOD;

BLOOD SUBSTITUTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HEMOGLOBINS; HUMANS; LIPOSOMES; OXYGEN; TIME FACTORS;

EID: 57449097000     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31857     Document Type: Article

References (25)

1. Djordjevich L, Miller IF. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol 1980;8:584-592.
2. Phillips WT, Klipper RW, Awasthi VD, Rudolph AS, Cliff R, Kwasiborski V, Goins BA. Polyethylene glycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute. J Pharmacol Exp Ther 1999;288:665-670.
3. Chang TM. Hemoglobin-based red blood cell substitutes. Artif Organs 2004;28:789-794.
4. Sakai H, Takeoka S, Park SI, Kose T, Nishide H, Izumi Y, Yoshizu A, Kobayashi K, Tsuchida E. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats. Bioconjugate Chem 1997;8:23-30.
5. Sakai H, Masada Y, Horinouchi H, Yamamoto M, Ikeda E, Takeoka S, Kobayashi K, Tsuchida E. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats. Crit Care Med 2004;32:539-545.
6. Cabrales P, Sakai H, Tsai AG, Takeoka S, Tsuchida E, Intaglietta M. Oxygen transport by low and normal oxygen affinity hemoglobin vesicles in extreme hemodilution. Am J Physiol Heart Circ Physiol 2005;288:H1885-H1892.
7. Yoshizu A, Izumi Y, Park S, Sakai H, Takeoka S, Horinouchi H, Ikeda E, Tsuchida E, Kobayashi K. Hemorrhagic shock resuscitation with an artificial oxygen carrier, hemoglobin vesicle, maintains intestinal perfusion and suppresses the increase in plasma tumor necrosis factor-α. ASAIO J 2004;50:458-463.
8. Wakamoto S, Fujihara M, Abe H, Yamaguchi M, Azuma H, Ikeda H, Takeoka S, Tsuchida E. Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro. Artif Cells Blood Subs Biotechnol 2005;33:101-111.
9. Ito T, Fujihara M, Abe H, Yamaguchi M, Wakamoto S, Takeoka S, Sakai H, Tsuchida E, Ikeda H, Ikebuchi K. Effects of poly(ethyleneglycol)-modified hemoglobin vesicles on N-formyl-methionyl-leucyl-phenylalanine-induced responses of polymorphonuclear neutrophils in vitro. Artif Cells Blood Substit Immobil Biotechnol 2001;29:427-437.
10. Abe H, Fujihara M, Azuma H, Ikeda H, Ikebuchi K, Takeoka S, Tsuchida E, Harashima H. Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: Effects on coagulation, kallikrein-kinin, and complement systems. Artif Cells Blood Substit Immobil Biotechnol 2006;34:1-10.
11. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-160.
12. Sou K, Klipper R, Goins B, Tsuchida E, Phillips WT. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J Pharmacol Exp Ther 2005;312:702-709.
13. Sakai H, Horinouchi H, Tomiyama K, Ikeda E, Takeoka S, Kobayashi K, Tsuchida E. Hemoglobin-vesicles as oxygen carriers: Influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am J Pathol 2001;159:1079-1088.
14. Sakai H, Horinouchi H, Yamamoto M, Ikeda E, Takeoka S, Takaori M, Tsuchida E, Kobayashi K. Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: Degradation of HbV and erythropoiesis in a rat spleen for 2 weeks. Transfusion 2006;46:339-347.
15. Abe H, Azuma H, Yamaguchi M, Fujihara M, Ikeda H, Sakai H, Takeoka S, Tsuchida E. Effects of hemoglobin vesicles, a liposomal artificial oxygen carrier, on hematological responses, complement and anaphylactic reactions in rats. Artif Cells Blood Substit Immobil Biotechnol 2007;35:157-172.
16. Pessina A, Malerba I, Gribaldo L. Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials. Curr Pharm Des 2005;11:1055-1065.
17. Sakai H, Yuasa M, Onuma H, Takeoka S, Tsuchida E. Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: Objective comparison between cellular and acellular types. Bioconjugate Chem 2000;11:56-64.
18. Sou K, Naito Y, Endo T, Takeoka S, Tsuchida E. Effective encapsulation of proteins into size-controlled phospholipid vesicles using freeze-thawing and extrusion. Biotechnol Prog 2003;19:1547-1552.
19. Sakai H, Hisamoto S, Fukutomi I, Sou K, Takeoka S, Tsuchida E. Detection of lipopolysaccharide in hemoglobin-vesicles by Limulus amebocyte lysate test with kinetic-turbidimetric gel clotting analysis and pretreatment of surfactant. J Pharm Sci 2004;93:310-321.
20. Lipton JM, Nathan DG. The anatomy and physiology of hematopoiesis. In: Nathan DG, Oski FA, editors. Hematology of Infancy and Childhood. Philadelphia: WB Saunders; 1987. p 128-158.
21. Ohkawara JI, Ikebuchi K, Fujihara M, Sato N, Hirayama F, Yamaguchi M, Mori KJ, Sekiguchi S. Culture system for extensive production of CD19+IgM+ cells by human cord blood CD34+ progenitors. Leukemia 1998;12:764-771.
22. Giarratana MC, Kobari L, Lapillonne H, Chalmers D, Kiger L, Cynober T, Marden MC, Wajcman H, Douay L. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005;23:69-74.
23. Unverzagt KL, Bender JG, Loudovaris M, Martinson JA, Hazelton B, Weaver C. Characterization of a culture-derived CD15+CD11b- promyelocyte population from CD34+ peripheral blood cells. J Leukoc Biol 1997;62:480-484.
24. Teramura Y, Kanazawa H, Sakai H, Takeoka S, Tsuchida E. Prolonged oxygen-carrying ability of hemoglobin vesicles by coencapsulation of catalase in vivo. Bioconjugate Chem 2003;14:1171-1176.
25. Fowler DA, Rsosenthal GJ, Sommadossi JP. Effect of recombinant human hemoglobin on human bone marrow progenitor cells: protection and reversal of 3′-azido-3′-deoxythymidine-induced toxicity. Toxicol Lett 1996;85:55-62.